XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Collaboration and other research and development revenues $ 7,543 $ 61 $ 15,779 $ 1,710
Revenue type Service [Member] Service [Member] Service [Member] Service [Member]
Operating expenses:        
Research and development $ 19,775 $ 47,639 $ 62,549 $ 150,636
General and administrative 12,316 18,088 38,550 55,633
Restructuring and impairment charges 0 0 66,935 0
Total operating expenses 32,091 65,727 168,034 206,269
Operating loss (24,548) (65,666) (152,255) (204,559)
Other (expense) income, net:        
Interest expense related to sale of future revenues (2,399) 0 (6,635) 0
Interest income, net 1,831 3,530 6,634 12,861
Other expense, net (1) (5) (2,184) 0
Total other (expense) income, net (569) 3,525 (2,185) 12,861
Net loss $ (25,117) $ (62,141) $ (154,440) $ (191,698)
Net loss per share, basic (in dollars per share) $ (0.28) $ (0.75) $ (1.80) $ (2.33)
Net loss per share, diluted (in dollars per share) $ (0.28) $ (0.75) $ (1.80) $ (2.33)
Weighted-average common shares outstanding, basic (in shares) 90,090,397 82,485,199 85,878,325 82,245,679
Weighted-average common shares outstanding, diluted (in shares) 90,090,397 82,485,199 85,878,325 82,245,679